Skip to main content
Healthy Skeptic
search
Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts
  • search
Close Search

Commentary

 

Sep 19 2018

Reference Pricing for Drugs

By Kevin Roche Commentary No Comments
A Commonwealth Fund brief looks at using reference pricing for drugs.
Read More
Sep 18 2018

The Status of Medicare Clinician Reimbursement

By Kevin Roche Commentary No Comments
A MedPAC presentation covers clinician payment trends and analysis.
Read More
Sep 17 2018

Disparities in Health Care

By Kevin Roche Commentary No Comments
A study published in the Journal of the American Medical Association examines disparities in hospitalization outcomes.
Read More
Sep 14 2018

Biosimilar Uptake

By Kevin Roche Commentary No Comments
JAMA has a couple of interesting research letters regarding uptake of biosimilars.
Read More
Sep 13 2018

Efficiency in the US Health Care System

By Kevin Roche Commentary No Comments
Prominent health economist Victor Fuchs discusses the "efficiency" of the US health care system.
Read More
Sep 12 2018

Health Insurers Are Doing Just Fine

By Kevin Roche Commentary No Comments
A Mark Farrah Associates brief shows that as of mid-year, health plans are having good results across all lines of business.
Read More
Sep 11 2018

The Medicare Bundled Payment for Joint Replacement Demonstration

By Kevin Roche Commentary No Comments
Two studies in the Journal of the American Medical Association discuss results from the first year of the Medicare joint replacement bundled payment demonstration.
Read More
Sep 10 2018

So What is Happening with Premiums in Exchange-Land?

By Kevin Roche Commentary No Comments
Hard to figure out what is really happening with premiums for health insurance purchased on the reform law exchanges.
Read More
Sep 07 2018

PBMs Blame Drug Companies for High Prices

By Kevin Roche Commentary No Comments
Today, we hear from the PBM trade association, pointing (or giving) the finger at medication makers for high prices.
Read More
Sep 06 2018

High Drug Prices Are Hospitals’ Fault, According to Drug Makers

By Kevin Roche Commentary No Comments
In the frenzy over drug prices, all sides are releasing studies on who is to blame. Here is one sponsored by the drug manufacturers' trade association.
Read More
  • « Previous
  • 1
  • …
  • 398
  • 399
  • 400
  • 401
  • 402
  • …
  • 643
  • Next »

✅ Receive notifications of new posts by email.

About this Blog

Kevin RocheThe Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.

Healthy Skeptic Podcast

Research

This is an outstanding report on total global drug spending and trends, with projections out to 2025.  It helps you understand this important area of health care, which does much...
June 1, 2021
The Office of the Actuary annual report on national health spending, covering 2018.
December 7, 2019
2019 Kaiser Family Foundation Employer Health Benefits Report
October 1, 2019
MedPAC 2019 Report to Congress
June 18, 2019

Headlines

IKS Health, a British company with a US subsidiary that offers “care enablement” and mentions AI, of course,  is buying TruBridge for $557 million.  TruBridge offers revenue cycle management and...
April 30, 2026
Innovacer, which basically collects data on a patient from multiple sources and aggregates it, raised an astounding $275 million in new capital, supposedly at a valuation of almost $3.5 billion....
April 22, 2026
A company called Whoop raised a ridiculous $575 million in new capital at a supposed $10 billion valuation.  The press release was released on April 1, so I would like...
April 5, 2026
Big deals continue in health care financings.  eMed, which manages weight loss medications for employers, raises a hefty $200 million, giving it a valuation of $2 billion, which seems crazy....
March 31, 2026

Tags

Access (89) ACO (165) Care Management (268) Chronic Disease (216) Comparative Effectiveness (81) Consumer Directed Health (71) Consumers (514) Devices (168) Disease Management (149) Drugs (605) EHRs (145) Elder Care (149) End-of-Life Care (97) FDA (85) Financings (1844) Genomics (80) Government (357) Health Care Costs (1428) Health Care Quality (616) Health Care Reform (1227) Health Insurance (1116) Health Insurance Exchange (162) HIT (478) HomeCare (76) Hospital (490) Hospital Readmissions (79) Legislation (78) M&A (1723) Malpractice (84) Meaningful Use (105) Medicaid (334) Medical Care (346) Medicare (607) Medicare Advantage (80) Mobile (89) Pay For Performance (92) Pharmaceutical (211) Physicians (569) Providers (252) Regulation (72) Repealing Reform (133) Telehealth (79) Telemedicine (325) Wellness and Prevention (316) Workplace (117)

About This Blog

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry through Roche Consulting, LLC. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached at khroche@healthy-skeptic.com. © Roche Consulting, LLC. Terms of Use.

Categories

  • Commentary
  • Headlines
  • Research

Useful Links

  • Congressional Budget Office
  • Health Affairs

RSS Feed

RSS feed

© 2026 Healthy Skeptic.

  • twitter
  • facebook
  • linkedin
Close Menu
  • Commentary
  • Headlines
  • Research
  • Useful Links
  • About & Contact
  • Podcasts